HUTCHMED (China) Limited (HCM)
NASDAQ: HCM · Real-Time Price · USD
15.45
-0.39 (-2.46%)
Jun 25, 2025, 4:00 PM - Market closed
HUTCHMED (China) Market Cap
HUTCHMED (China) has a market cap or net worth of $2.63 billion as of June 26, 2025. Its market cap has decreased by -14.96% in one year.
Market Cap
2.63B
Enterprise Value
1.83B
1-Year Change
-14.96%
Ranking
Category
Stock Price
$15.45
Market Cap Chart
Since March 17, 2016, HUTCHMED (China)'s market cap has increased from $1.60B to $2.63B, an increase of 64.77%. That is a compound annual growth rate of 5.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2025 | 2.70B | 7.45% |
| Dec 31, 2024 | 2.51B | -19.95% |
| Dec 29, 2023 | 3.14B | 22.75% |
| Dec 30, 2022 | 2.56B | -50.05% |
| Dec 31, 2021 | 5.12B | 19.79% |
| Dec 31, 2020 | 4.27B | 27.79% |
| Dec 31, 2019 | 3.34B | 8.92% |
| Dec 31, 2018 | 3.07B | -35.89% |
| Dec 29, 2017 | 4.79B | 195.91% |
| Dec 30, 2016 | 1.62B | 1.27% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 698.51B |
| Johnson & Johnson | 366.18B |
| AbbVie | 327.76B |
| Novo Nordisk | 313.40B |
| UnitedHealth Group | 277.24B |
| Abbott Laboratories | 240.24B |
| Novartis AG | 232.39B |
| AstraZeneca | 218.32B |